Image Place holder

Lucia Seminario-Vidal, MD, PhD

Specialty: Dermatology
Program: Cutaneous Oncology


Cancer Focus: Basal Cell Carcinoma, Cutaneous Lymphoma (CTCL), Melanoma, Skin Cancer (Nonmelanoma)

Dr. Lucia Seminario-Vidal is a board-certified dermatologist in the Department of Cutaneous Oncology at Moffitt and an assistant professor in the University of South Florida (USF) Department of Dermatology. She is the associate director of dermatology clinical research, and the director of the dermatology consult service providing inpatient dermatology services at Moffitt. Dr. Seminario specializes in general and complex dermatology, with a special interest in cutaneous lymphomas, drug eruptions, cutaneous diseases in immunocompromised patients, and skin cancers. Dr. Seminario is also the lead dermatologist of the multidisciplinary cutaneous lymphoma clinic at Moffitt. In this multidisciplinary clinic, each patient’s care plan is reviewed by a highly expert team of physicians with extensive, focused training in their area of specialty, giving them additional insights and knowledge to help make the best treatment decisions. Dr. Seminario enjoys working with medical students and residents in clinic as well as in scholarly activities and research projects. During her career, she has received numerous awards related to her clinical and research endeavors. She is widely published, and has presented her work at diverse local, regional, national, and international meetings. She has developed investigator initiated studies and has participated in more than 30 clinical trials. She is a fellow of the American Academy of Dermatology, and an active member of the International Cutaneous Lymphoma Society, the United States Cutaneous Lymphoma Society, and the Society of Investigative Dermatology. She participates in national committees, including the scientific committee of the Society of Dermatology Hospitalists and the external grants committee of the Women Dermatologic Society.

Education & Training


  • University of Alabama Birmingham - Clinical Trials


  • University of Alabama Birmingham - Dermatology

Medical School:

  • Universidad Peruana Cayetano Heredia Medical School - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Gabel CK, Nguyen E, Karmouta R, Liu KJ, Zhou G, Alloo A, Arakaki R, Balagula Y, Bridges AG, Cowen EW, Davis MDP, Femia A, Harp J, Kaffenberger B, Keller JJ, Kwong BY, Markova A, Mauskar M, Micheletti R, Mostaghimi A, Pierson J, Rosenbach M, Schwager Z, Seminario-Vidal L, Sharon VR, Song PI, Strowd LC, Walls AC, Wanat KA, Wetter DA, Worswick S, Ziemer C, Kvedar J, Mikailov A, Kroshinsky D. Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease. J Am Acad Dermatol. 2021 Jun.84(6):1547-1553. Pubmedid: 32389716. Pmcid: PMC7204758.
  • Daou H, Paradiso M, Hennessy K, Seminario-Vidal L. Rosacea and the Microbiome: A Systematic Review. Dermatol Ther (Heidelb). 2021 Feb.11(1):1-12. Pubmedid: 33170492. Pmcid: PMC7859152.
  • Daou H, Hatch LA, Weinkle A, Morey GE, Messina J, Zhang X, Sokol L, Seminario-Vidal L. CD8-positive cutaneous lymphoproliferation associated with large granular lymphocyte leukemia in a patient with X-linked agammaglobulinemia. J Cutan Pathol. 2021 Apr.48(4):567-571. Pubmedid: 32885480.
  • Weinkle A, Kaffenberger BH, Trinidad JC, Ergen EN, Keller J, Seminario-Vidal L. Reply to: "Response: Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review". J Am Acad Dermatol. 2020 Mar.82(3):e113. Pubmedid: 31712175.
  • Seminario-Vidal L, Kroshinsky D, Malachowski SJ, Sun J, Markova A, Beachkofsky TM, Kaffenberger BH, Ergen EN, Mauskar M, Bridges A, Calhoun C, Cardones AR, Chen ST, Chodosh J, Cotliar J, Davis MDP, DeNiro KL, Dominguez AR, Eljure-Téllez J, Femia A, Fox LP, Guda A, Mitchell C, Mostaghimi A, Ortega-Loayza AG, Owen C, Pasieka H, Rahnama-Moghadam S, Saeed HN, Saunderson RB, Shanbhag S, Sharon VR, Strowd L, Venkatesh S, Wanat KA, Wetter DA, Worswick S, Micheletti RG. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. J Am Acad Dermatol. 2020 Mar.82(6):1553-1567. Pubmedid: 32151629.
  • Cohen L, Shah V, Chen PL, Messina J, Seminario-Vidal L. Cutaneous squamous cell carcinoma causing a rhinophymatous mass in a patient with clinically occult hypertrophic lupus erythematosus. Lupus. 2020 Mar.29(6):644-648. Pubmedid: 32202198.
  • Shah N, Cohen L, Seminario-Vidal L. Management of oral reactions from immune checkpoint inhibitor therapy: A systematic review. J Am Acad Dermatol. 2020 Jun.83(5):1493-1498. Pubmedid: 32502589.
  • Malachowski SJ, Hatch LA, Sokol L, Messina J, Seminario-Vidal L. Pembrolizumab-associated tumor development in a patient with Sézary syndrome. JAAD Case Rep. 2020 Jan.6(1):16-18. Pubmedid: 31909130. Pmcid: PMC6938917.
  • Haynes D, Hammer P, Malachowski SJ, Kaffenberger B, Yi JS, Vera N, Calhoun C, Shinohara MM, Seminario-Vidal L, Trinidad JC, Keller JJ, Ortega-Loayza AG. Characterisation and diagnosis of ulcers in inpatient dermatology consultation services: A multi-centre study. Int Wound J. 2019 Sep.16(6):1440-1444. Pubmedid: 31475449. Pmcid: PMC7948787.
  • Moy A, Sun J, Ma S, Seminario-Vidal L. Lymphomatoid Papulosis and Other Lymphoma-Like Diseases. Dermatol Clin. 2019 Oct.37(4):471-482. Pubmedid: 31466587.
  • Malachowski SJ, Sun J, Chen PL, Seminario-Vidal L. Diagnosis and Management of Cutaneous B-Cell Lymphomas. Dermatol Clin. 2019 Oct.37(4):443-454. Pubmedid: 31466585.
  • Ayoubi N, Haque A, Vera N, Ma S, Messina J, Khushalani N, Seminario-Vidal L. Ipilimumab/nivolumab-induced pseudolymphoma in a patient with malignant melanoma. J Cutan Pathol. 2019 Nov.47(4):390-393. Pubmedid: 31677178.
  • Metterle L, Hatch L, Seminario-Vidal L. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature. Pediatr Dermatol. 2019 Nov.37(1):124-129. Pubmedid: 31691347.
  • Le NK, Billington A, Harrington M, Seminario-Vidal L. Management of Recessive Dystrophic Epidermolysis Bullosa in a Newborn with Porcine-derived Extracellular Matrix. Plast Reconstr Surg Glob Open. 2019 Nov.7(11):e2519. Pubmedid: 31942309. Pmcid: PMC6908358.
  • Weinkle A, Pettit C, Jani A, Keller J, Lu Y, Malachowski S, Trinidad JC, Kaffenberger BH, Ergen EN, Hughey LC, Smith D, Seminario-Vidal L. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review. J Am Acad Dermatol. 2019 May.81(3):749-757. Pubmedid: 31150704.
  • Lilly E, Bunick CG, Maley AM, Zhang S, Spraker MK, Theos AJ, Vivar KL, Seminario-Vidal L, Bennett AE, Sidbury R, Ogawa Y, Akiyama M, Binder B, Hadj-Rabia S, Morotti RA, Glusac EJ, Choate KA, Richard G, Milstone LM. More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations. J Am Acad Dermatol. 2019 Mar.80(3):617-625. Pubmedid: 30287322. Pmcid: PMC6372339.
  • Hatch LA, Laurain D, Messina J, Seminario-Vidal L. An erythematous facial rash. J Fam Practice. 2019 Dec.68(10):E9-E11. Pubmedid: 31860705.
  • Cohen L, Chen PL, Zhang L, Sokol L, Seminario-Vidal L. Skin-first nodulotumoral adult T-cell lymphoma mimicking cutaneous T-cell lymphoma. JAAD Case Rep. 2019 Aug.5(8):650-652. Pubmedid: 31388529. Pmcid: PMC6677771.
  • Cohen L, Haque A, Ma S, Zhang L, Sokol L, Seminario-Vidal L. T-cell prolymphocytic leukemia presenting with erythematous patches, plaques, and erythema gyratum-like lesions masquerading as Sézary syndrome. JAAD Case Rep. 2019 Aug.5(8):686-690. Pubmedid: 31440557. Pmcid: PMC6698441.
  • Hatch LA, Ma S, Seminario-Vidal L. Purpuric ecchymoses in the elderly: senile purpura or hematologic malignancy? A case of blastic plasmacytoid dendritic cell neoplasm. Int J Dermatol. 2019 Aug. Pubmedid: 31468501.
  • Castillo B, Vera N, Ortega-Loayza AG, Seminario-Vidal L. Wound care for Stevens-Johnson Syndrome and toxic epidermal necrolysis; A Systematic Review. J Am Acad Dermatol. 2018 Mar. Pubmedid: 29601936.
  • He Y, Seminario-Vidal L, McLeod HL. Avoidance of Severe Cutaneous Adverse Drug Events as a First Step in Precision Neurology. JAMA Neurol. 2018 Jul.75(7):793-795. Pubmedid: 29610896.
  • Choi H, Castillo B, Seminario-Vidal L. Silver absorption in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis treated with silver-impregnated dressings. A case series. Int Wound J. 2018 Dec.15(6):1049-1051. Pubmedid: 29893032. Pmcid: PMC7949585.
  • Castillo B, Gibbs J, Brohl AS, Seminario-Vidal L. Checkpoint inhibitor-associated cutaneous small vessel vasculitis. JAAD Case Rep. 2018 Aug.4(7):675-677. Pubmedid: 30112452. Pmcid: PMC6092526.
  • Vera N, Patel NU, Seminario-Vidal L. Rosacea Comorbidities. Dermatol Clin. 2018 Apr.36(2):115-122. Pubmedid: 29499794.
  • Nethers K, Messina J, Seminario-Vidal L. Eccrine squamous syringometaplasia in an allogenic stem cell transplant patient undergoing chemotherapy. Dermatol Online J. 2017 Sep.23(9). Pubmedid: 29469718.
  • Laurain D, Seminario-Vidal L, Rodriguez-Waitkus P, Shenefelt P. Tense Bullae on the Penile Shaft: Challenge. Am J Dermatopathxxx. 2017 Nov.39(11):e156-e157. Pubmedid: 29053552.
  • Laurain D, Seminario-Vidal L, Rodriguez-Waitkus P, Shenefelt P. Tense Bullae on the Penile Shaft: Answer. Am J Dermatopathxxx. 2017 Nov.39(11):870. Pubmedid: 29053549.
  • Oak AS, Seminario-Vidal L, Sami N. Treatment of antiviral-resistant recurrent erythema multiforme with dapsone. Dermatol Ther. 2017 Mar.30(2). Pubmedid: 27860166.
  • Vivar KL, Deschaine M, Messina J, Divine JM, Rabionet A, Patel N, Harrington MA, Seminario-Vidal L. Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy. J Cutan Pathol. 2017 Apr.44(4):381-384. Pubmedid: 28000240.
  • Seminario-Vidal L, Kole L, Knapp C, Fort P, Kankirawatana S, Atkinson TP, McKay KM, Theos A. Dermatological clues to the diagnosis of atypical complete DiGeorge syndrome. Dermatol Online J. 2016 Nov.22(11). Pubmedid: 28329565.
  • Weinkle AP, Patel N, Kissel R, Seminario-Vidal L. Acquired acrodermatitis enteropathica as a presenting sign of celiac disease. JAAD Case Rep. 2016 May.2(3):193-195. Pubmedid: 27222886. Pmcid: PMC4873608.
  • Makeeva V, Seminario-Vidal L, Beckum K, Sami N. Bilateral periorbital swelling as the initial presentation of cutaneous lupus erythematosus. JAAD Case Rep. 2016 Jan.2(1):72-76. Pubmedid: 27051834. Pmcid: PMC4809478.
  • Seminario-Vidal L, Jensen JD, Fening K, McKay K, Elmets C, Theos A. Long-Standing Spicules in a Patient with Acute Lymphoblastic Leukemia. Pediatr Dermatol. 2016 Apr.32(4):545-546. Pubmedid: 25691258.
  • Seminario-Vidal L, Guerrero C, Sami N. Refractory Sweet's syndrome successfully treated with rituximab. JAAD Case Rep. 2015 May.1(3):123-125. Pubmedid: 27051705. Pmcid: PMC4808708.
  • Pavlidakey PG, Seminario-Vidal L, McKay KM, Sami N. Spirochete immunostaining is not just for syphilis: diagnostic utility in borreliosis. J Cutan Pathol. 2015 May.42(5):370-372. Pubmedid: 25918979.
  • Seminario-Vidal L, Hughey LS. Hydroxychloroquine de Novo-Induced Psoriasis in a Patient With Lichen Planus Pigmentosus. Skinmed. 2015 Dec.13(6):492-494. Pubmedid: 26861533.
  • Seminario-Vidal L, Sami N, Miller J, Theos A. Mycophenolate mofetil therapy for pediatric bullous pemphigoid. Dermatol Online J. 2015 Aug.21(8). Pubmedid: 26437160.
  • Seminario-Vidal L, Cantrell W, Elewski BE. Pulmonary Cryptococcosis in the Setting of Tofacitinib Therapy for Psoriasis. J Drugs Dermatol. 2015 Aug.14(8):901-902. Pubmedid: 26267737.
  • Hunt KM, Kissel R, Seminario-Vidal L. Progressive widespread cutaneous telangiectasias. JAMA Dermatol. 2014 Oct.150(10):1103-1104. Pubmedid: 25142837.
  • Okada SF, Ribeiro CM, Sesma JI, Seminario-Vidal L, Abdullah LH, van Heusden C, Lazarowski ER, Boucher RC. Inflammation promotes airway epithelial ATP release via calcium-dependent vesicular pathways. Am J Respir Cell Mol Biol. 2013 Nov.49(5):814-820. Pubmedid: 23763446. Pmcid: PMC3931099.
  • Seminario-Vidal L, van Heusden C, Mugesh G, Lazarowski ER. Erratum to: Ebselen is a potent non-competitive inhibitor of extracellular nucleoside diphosphokinase. Purinergic Signal. 2011 Jun.7(2):277. Pubmedid: 21494852. Pmcid: PMC3146640.
  • Seminario-Vidal L, Okada SF, Sesma JI, Kreda SM, van Heusden CA, Zhu Y, Jones LC, O'Neal WK, Penuela S, Laird DW, Boucher RC, Lazarowski ER. Rho signaling regulates pannexin 1-mediated ATP release from airway epithelia. J Biol Chem. 2011 Jul.286(30):26277-26286. Pubmedid: 21606493. Pmcid: PMC3143590.
  • Kreda SM, Seminario-Vidal L, van Heusden CA, O'Neal W, Jones L, Boucher RC, Lazarowski ER. Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides. J Physiol. 2010 Jun.588(Pt 12):2255-2267. Pubmedid: 20421285. Pmcid: PMC2911224.
  • Seminario-Vidal L, Kreda S, Jones L, O'Neal W, Trejo J, Boucher RC, Lazarowski ER. Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of rho- and Ca2+-dependent signaling pathways. J Biol Chem. 2009 Jul.284(31):20638-20648. Pubmedid: 19439413. Pmcid: PMC2742828.
  • Seminario-Vidal L, Lazarowski ER, Okada SF. Assessment of extracellular ATP concentrations. Methods Mol Biol. 2009 Dec.574:25-36. Pubmedid: 19685297.
  • Van Itallie CM, Rogan S, Yu A, Vidal LS, Holmes J, Anderson JM. Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal Physiol. 2006 Dec.291(6):F1288-F1299. Pubmedid: 16804102.

Patient Comments
Overall Satisfaction

patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments